Paraneoplastic syndrome is a group of rare autoimmune diseases that can occur due to lung cancer, especially small cell lung cancer (SCLC). The group of diseases occur due to the immune system ...

Paraneoplastic pemphigus is a rare autoimmune skin condition that causes blisters and oral lesions. It usually develops due to underlying cancer. Treatment is essential for managing symptoms and ...

Paraneoplastic neurologic disorders can affect any part of the nervous system (Table 1). Some of them affect only a single area (e.g., limbic encephalitis) or a single cell type (e.g., the Purkinje ...

The mechanisms of paraneoplastic thrombocytosis in ovarian cancer and the role that platelets play in abetting cancer growth are unclear. We analyzed clinical data on 619 patients with epithelial ...

Paraneoplastic syndromes (PNS) are a group of rare disorders caused by the presence of tumors in the body. They occur in about 10 to 15 percent of people with cancer and may develop before cancer is ...

IMACS guidelines are clinically useful for identifying high-risk populations, researchers ...

Paraneoplastic syndrome is a rare and poorly understood systemic manifestation of malignancy that can involve multiple organ systems. [1] Detection of the underlying malignancy is key to treatment.

Prostate cancer is the second most common urological malignancy to be associated with paraneoplastic syndromes after renal cell carcinoma. These syndromes tend to occur in the setting of late stage ...

Timely intervention led to a recovery in rare diseases. A 43-year-old housewife in South Suburban Kolkata experienced stroke-like symptoms linked to breast cancer. Doctors discovered Paraneoplastic ...

Paraneoplastic syndromes are a group of symptoms that happen in some people who have small-cell lung cancer (SCLC). Some paraneoplastic syndromes affect your nervous system, including your brain, ...

Paraneoplastic syndromes are rare groups of symptoms that affect some people with cancer. These symptoms aren’t directly caused by the spread of cancer but by: hormones and signaling molecules ...